110 related articles for article (PubMed ID: 36515824)
21. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
Zeng YT; Liu XF; Yang WT; Zheng PS
Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905
[TBL] [Abstract][Full Text] [Related]
22. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
[TBL] [Abstract][Full Text] [Related]
23. Endothelial cell-specific molecule 1 drives cervical cancer progression.
Lu J; Liu Q; Zhu L; Liu Y; Zhu X; Peng S; Chen M; Li P
Cell Death Dis; 2022 Dec; 13(12):1043. PubMed ID: 36522312
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis.
Su HC; Wu SC; Yen LC; Chiao LK; Wang JK; Chiu YL; Ho CL; Huang SM
Sci Rep; 2020 Jul; 10(1):11837. PubMed ID: 32678267
[TBL] [Abstract][Full Text] [Related]
25. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
[TBL] [Abstract][Full Text] [Related]
26. Expression of BMP7 in cervical cancer and inhibition of epithelial‑mesenchymal transition by BMP7 knockdown in HeLa cells.
Sun R; Guan H; Liu W; Liang J; Wang F; Li C
Int J Mol Med; 2020 May; 45(5):1417-1424. PubMed ID: 32323730
[TBL] [Abstract][Full Text] [Related]
27. Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition.
Huang ZY; Liao PJ; Liu YX; Zhong M; Sun AH; Jiang XC; Wang XP; Zhang M
Bioengineered; 2021 Dec; 12(1):5739-5748. PubMed ID: 34516350
[TBL] [Abstract][Full Text] [Related]
28. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
Liu H; Zhang L; Ding X; Sui X
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
[TBL] [Abstract][Full Text] [Related]
29. MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.
Wang D; Wang H; Li Y; Li Q
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871972
[TBL] [Abstract][Full Text] [Related]
30. E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer.
Kim LK; Park SA; Eoh KJ; Heo TH; Kim YT; Kim HJ
Int J Biol Sci; 2020; 16(2):320-329. PubMed ID: 31929759
[TBL] [Abstract][Full Text] [Related]
31. miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer.
Wang N; Li Y; Zhou J
Biomed Res Int; 2017; 2017():6361420. PubMed ID: 29159179
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
33. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.
Zhang F; Zhou Q
Mol Med Rep; 2018 Dec; 18(6):4886-4894. PubMed ID: 30272359
[TBL] [Abstract][Full Text] [Related]
35. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
Tyszka-Czochara M; Lasota M; Majka M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896
[TBL] [Abstract][Full Text] [Related]
36. LINC00319 promotes migration, invasion and epithelial-mesenchymal transition process in cervical cancer by regulating miR-3127-5p/RPP25 axis.
Yang J; Hou S; Liang B
In Vitro Cell Dev Biol Anim; 2020 Feb; 56(2):145-153. PubMed ID: 31942724
[TBL] [Abstract][Full Text] [Related]
37. LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1.
Feng Y; Qu L; Wang X; Liu C
Cancer Biol Ther; 2019; 20(12):1453-1461. PubMed ID: 31390932
[TBL] [Abstract][Full Text] [Related]
38. Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.
Jiang Y; Ren W; Wang W; Xia J; Gou L; Liu M; Wan Q; Zhou L; Weng Y; He T; Zhang Y
Oncol Rep; 2017 Nov; 38(5):2597-2606. PubMed ID: 29048651
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal transition by targeting AEG-1 in cervical cancer.
Wang Z; He S; Guo P; Guo X; Zheng J
Oncol Rep; 2017 Nov; 38(5):3121-3129. PubMed ID: 29048632
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte nuclear factor 6 suppresses the migration and invasive growth of lung cancer cells through p53 and the inhibition of epithelial-mesenchymal transition.
Yuan XW; Wang DM; Hu Y; Tang YN; Shi WW; Guo XJ; Song JG
J Biol Chem; 2013 Oct; 288(43):31206-16. PubMed ID: 24022481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
